Air Disinfection Applications - MolecuCare Ultraviolet

UV Air, Water & SURFACE Disinfection Technologies

M o l e c u C a r e ®

the world'S MOST POWERFUL ultraviolet IRRADIATION SYSTEMS

HOME

HISTORY

UV AIR DISINFECTION SYSTEMS

AIR DISINFECTION APPLICATIONS

UV WATER DISINFECTION SYSTEMS

WATER DISINFECTION APPLICATIONS

EPA Report: "MolecuCare Air and Water Disinfection"

INDEPENDENT LABORATORY TEST RESULTS

UV READING LINKS LIBRARY

CONTACT MOLECUCARE

COMPANY PRINCIPALS & ADVISORS

Market Potentials for MolecuCare's Steady-State™ Air Disinfection Technology

General Building Applications

In the United States alone, the potential for more effective & lower energy-consuming air treatment designs is simply enormous. There are currently about 90 million buildings in the U.S.; nearly $400 billion is spent annually on new construction in addition to $200 billion spent on renovation, repair & modification; excluding all government, Post Office and military structures, about $115 billion is spent in the U.S. annually for the energy to power heating, cooling and ventilation systems alone. Because MolecuCare system designs kill pathogens which can pass through HEPA filters, the filters can be eliminated - lowering energy costs and removing the expense of buying, replacing and disposing of HEPA filters. See UV Reading Links

Because of the scalability of the Steady-State™ Chamber© design, its pathogen removal power and energy efficiency can be applied to any type of structure. In the residential market, "over 75 million Americans annually suffer allergic reactions to such airborne pollutants as dust mites, various pollens, cat and other pet dander, and the parasitic fungal spores commonly called mold" (U.S. National Institutes of Health). The NIH also states that children under the age of ten years exposed to these allergens are roughly twice as likely to develop hay fever symptoms and other allergic reactions as adults.

"The MolecuCare Steady-State™ Chamber© kills Aspergillus niger mold spores requiring 30-50 times the UV exposure levels required to kill Tuberculosis or Anthrax bacilli." - See Independent Laboratory Test Results

As in residences, common HVAC ductwork and air conditioning condensers create an equally widespread market potential for better air treatment in all public buildings. Over 100 million people in the U.S. work 40 hours or more per week indoors, over 3 million children are in daycare facilities daily, and U.S. citizens gather in a million restaurants, bars and theaters daily. Various federal studies indicate that periodic or daily exposure to airborne allergens, bacteria, viruses and fungal spores have significant negative effects on especially children, the elderly and persons with chronic heart, lung or allergic conditions.

The U.S. National Resources Defense Council estimates "over 65,000 Americans die annually from air pollution-affected cardiopulmonary illnesses". With energy conservation driving the development of ever more efficient construction techniques and materials, indoor air quality is a matter of growing public health interest and expense.

Hospital & Other Applications

The U.S. Centers for Disease Control estimates that nosocomial, or "hospital acquired", illnesses affect 2 million patients, visitors and staff annually. The CDC estimates airborne bacterial and viral infections are principally responsible for most of the 90,000 annual U.S. nosocomial fatalities, although airborne fungi and parasites are also known to spread various forms of pneumonias. Ironically, the leading cause of U.S. nosocomial fatalities annually is pneumonias contracted by patients in intensive care units.

Sadly, the spread of innumerable airborne diseases inside of hospitals, ranging from flus to pneumonia to tuberculosis, has been extensively documented for decades and remains a serious and costly problem globally.

MolecuCare's whole building in-duct ultraviolet air disinfection systems are specifically designed to address an entire isolation unit, a complete floor, or an entire building. The Steady-State™ Chamber© concept was specifically developed from the outset to address nosocomial infection by treating all the air passing through an entire HVAC system; these designs have been independently rigorously tested and stand ready for immediate manufacture and installation. See History

MolecuCare UV Air Disinfection: Early Prototype Mobile Chamber Test Model in an NYC Hospital 1998

Pictured above; long term beta testing of early mobile prototype H-10 UV air disinfection units in one of several hospitals.

"People with allergies or weakened immune systems are especially susceptible to the mold spores, bacteria and fungi which linger on air conditioning evaporators." - CDC

Additional market applications for a more economical and predictable air control system are virtually limitless: any public space (medical/dental offices, schools, research/laboratory facilities, detention centers, retailers, libraries, convalescent & retirement facilities, etc) is an obvious candidate.

Additionally, the scalability by design of the Steady-State™ Chamber© allows a range of potential transportation applications: in the U.S. alone, over 6 million people use public transportation daily, over 15 million carpool, and 60% spend over 45 minutes in these environments. The Chamber© can be sized for effective use in virtually any private, public or military ground, rail, marine or air conveyance.